Keith Kelly
About Keith Kelly
Keith Kelly is the Associate Director at Bristol-Myers Squibb in Dublin, Ireland, with over 20 years of experience in the pharmaceutical and biopharmaceutical industries.
Company
Keith Kelly is currently an Associate Director at Bristol-Myers Squibb, based in Dublin, Ireland. He has been with the company since December 2017, accumulating over six years of experience in this role. His work involves responsibilities pertinent to the biopharmaceutical sector, leveraging his extensive background in the industry.
Title
Keith Kelly holds the title of Associate Director at Bristol-Myers Squibb. He previously held the role of Upstream Project Lead at Bristol-Myers Squibb from 2015 to 2017, based in New York, before relocating to Dublin. His roles at Bristol-Myers Squibb have included significant leadership and project management responsibilities.
Previous Roles at Bristol-Myers Squibb
Prior to his current role, Keith Kelly served as the Upstream Project Lead for BMS Cruiserath Biologics in New York from 2015 to 2017. This position involved overseeing upstream processing projects, contributing significantly to the company's biopharmaceutical advancements. His expertise in project leadership at Bristol-Myers Squibb enhances his current role as an Associate Director.
Career Experience
Keith Kelly has amassed over 20 years of experience in the pharmaceutical and biopharmaceutical industries. His career began as a Production Operator at Odenberg Engineering in Dublin in 2002. He later transitioned to roles at Wyeth Biopharma as a Cell Culture Process Technician and then to Pfizer, where he worked as a Manufacturing Technologist and Right First Time Specialist. He also held a position at Alexion Pharmaceuticals as a Senior Specialist. His diverse industry roles have equipped him with a comprehensive understanding of both biologics and pharmaceuticals.
Pharmaceutical and Biopharmaceutical Expertise
Keith Kelly's extensive background in the pharmaceutical and biopharmaceutical sectors includes roles at prominent companies such as Pfizer, Alexion Pharmaceuticals, and Bristol-Myers Squibb. His roles have spanned various aspects of production, manufacturing, and project leadership. His expertise includes upstream processing, cell culture processes, and quality specialization, highlighting his ability to contribute effectively to the biopharmaceutical industry's growth and innovation.